Go to the list of all blogs
published in Blogs
Jul 21, 2026
iShares Russell 2000 ETF (IWM) Delivers +20% in Q2 as Small Caps Lead the Market

iShares Russell 2000 ETF (IWM) Delivers +20% in Q2 as Small Caps Lead the Market

Key Takeaways

  • The iShares Russell 2000 ETF delivers diversified exposure to approximately 2,000 U.S. small-cap stocks across industrials, healthcare, financials, and information technology, with a competitive 0.19% expense ratio and roughly $83 billion in assets under management (AUM).
  • After surging more than 20% during the second quarter of 2026 — its strongest quarterly performance in years — IWM has entered a period of consolidation, moving roughly 1% lower over the past 30 days.
  • Small-cap stocks have broadly outperformed large-cap benchmarks year-to-date, driven by a combination of resilient economic growth, AI-driven demand filtering into smaller industrials and technology firms, and a Federal Reserve policy stance that has stabilized borrowing costs.
  • Approximately 30% of Russell 2000 debt carries floating interest rates, making the fund structurally more sensitive to Federal Reserve policy shifts than large-cap indexes.
  • Earnings growth for Russell 2000 constituents is projected near 19% for 2026, outpacing S&P 500 estimates and providing a fundamental underpinning for the small-cap rally.

Overview of the iShares Russell 2000 ETF (IWM)

The iShares Russell 2000 ETF, issued by BlackRock and launched in May 2000, seeks to track the investment results of the Russell 2000 Index — the most widely followed benchmark for U.S. small-capitalization equities. The index comprises approximately 2,000 of the smallest stocks within the broader Russell 3000 Index, representing roughly 7% of that index's total market capitalization.

IWM's portfolio spans roughly 2,000 holdings, with no single position exceeding 0.4% of the fund. Top holdings include Moog Inc, Cytokinetics, BrightSpring Health Services, UMB Financial, Viasat, JFrog, Krystal Biotech, Hut 8 Corp, and CareTrust REIT. Sector weights are led by industrials at approximately 19%, information technology near 18%, healthcare around 16%, and financials at roughly 16%, followed by consumer discretionary, energy, real estate, and materials. This balanced sector composition differentiates IWM from large-cap benchmarks that have grown increasingly concentrated in mega-cap technology stocks. When scanning for comparable names, I occasionally reference Tickeron’s AI tools to cross-check sector exposures.

The fund operates as a passive, market-cap-weighted vehicle with an expense ratio of 0.19%. Its deep liquidity and active options market make it a primary instrument for institutional investors executing small-cap allocation and hedging strategies.

The Small-Cap Landscape and Key Themes

Small-cap equities entered 2026 with significant tailwinds after years of relative underperformance versus large-cap peers. By late 2025, the valuation gap between the Russell 2000 and the S&P 500 had reached a multi-decade extreme, with small caps trading at approximately 18 times forward earnings versus 26 times for large caps. That discount, combined with a cooling inflation trajectory and three consecutive Federal Reserve rate cuts in late 2025, set the stage for a rotation into domestically oriented, interest-rate-sensitive companies.

Several structural themes now shape the small-cap landscape. Artificial intelligence (AI) investment has broadened beyond hyperscale cloud providers, creating demand for semiconductor supply-chain participants, data center infrastructure providers, and specialized software firms — many of which reside in the Russell 2000. In parallel, reshoring trends and domestic infrastructure spending have disproportionately benefited U.S.-focused small-cap industrials and manufacturers. Legislative changes, including the restoration of full R&D expensing and 100% bonus depreciation, have further improved cash flow for capital-intensive smaller firms.

However, risks remain pronounced. Roughly 30% of Russell 2000 constituent debt carries floating rates, compared to approximately 7% for the S&P 500. Interest expense now accounts for approximately 31% of EBITDA (earnings before interest, taxes, depreciation, and amortization) for Russell 2000 firms, a level that has more than doubled since 2020. Nearly 40% of Russell 2000 companies remain unprofitable. The June 2026 index reconstitution also halved the weight of AI infrastructure stocks within the benchmark, reducing a key performance driver from approximately 15% to 7%.

Recent Performance and Positioning

IWM delivered a standout second quarter, climbing approximately 20.4% from its April 1 closing level of $249.56 to $300.45 by June 30. That quarter represented the Russell 2000's strongest performance since the fourth quarter of 2020 and contributed to a year-to-date gain exceeding 19% through mid-July. For context, the S&P 500 advanced roughly 9-10% over the same period, underscoring the magnitude of the small-cap leadership rotation.

Over the most recent 30-day window, however, IWM has traded in a narrow range, edging roughly 1% lower as markets digested mixed signals. Oil prices spiked back above $80 per barrel amid renewed U.S.-Iran tensions, semiconductor stocks experienced a sharp pullback, and uncertainty surrounding the Federal Reserve's policy path under Chair Kevin Warsh kept risk appetite in check. The consolidation follows a powerful rally and reflects a market pausing to assess whether fundamental earnings growth can sustain small-cap valuations at current levels. One thing that stands out in the holdings is the performance of names like Moog Inc and Hut 8 Corp, which have each posted triple-digit gains over the past year.

The fund's top holdings reflect the breadth of the small-cap opportunity set. Moog Inc, a motion-control systems manufacturer, and Hut 8 Corp, a digital asset infrastructure company, have each posted triple-digit percentage gains over the past year, benefiting from industrial and crypto-related demand respectively. BrightSpring Health Services and Cytokinetics represent the healthcare segment, where clinical milestones and demographic trends continue to attract investor capital. The fund's granular composition — with no position exceeding 0.4% — means performance is driven by broad sector and macro trends rather than idiosyncratic single-stock moves.

Leveraging AI Tools in Small-Cap Research

Identifying opportunities across thousands of small-cap stocks can be resource-intensive, which is where Tickeron's AI Screener adds practical value. The platform applies artificial intelligence to scan equities and ETFs using a broad array of criteria, including technical indicators, fundamental metrics, volatility patterns, and AI-generated trading signals. Users can filter by sector, industry, market capitalization, and performance characteristics to surface securities that match specific investment criteria — whether seeking breakout candidates, momentum plays, or fundamentally sound names trading at attractive valuations. For investors navigating the expansive small-cap universe, the AI Screener offers an efficient way to narrow the field and identify actionable ideas aligned with evolving market conditions. I have found this approach helpful when building watchlists for names that fit the themes discussed above.

2026 Outlook and Factors to Watch

The trajectory of IWM through the remainder of 2026 will likely hinge on several interrelated factors. First among them is Federal Reserve policy: markets currently price a roughly 35-basis-point probability of tightening by year-end. Any rate increase would disproportionately pressure small caps given their higher floating-rate debt exposure. Conversely, if the Fed remains on hold and inflation continues to moderate, the rate environment could remain supportive for small-cap earnings.

Earnings execution represents the second critical variable. Russell 2000 constituents are projected to deliver approximately 19% year-over-year earnings growth for full-year 2026. If those estimates materialize — particularly in the industrials, financials, and healthcare segments that dominate the index — small caps could maintain their relative valuation advantage. At a forward price-to-earnings multiple near 17, the Russell 2000 continues to trade at a discount to the S&P 500's roughly 20 times earnings, suggesting room for further multiple expansion if earnings delivery remains on track. I'm watching earnings reports closely in the coming quarters to see how this plays out.

Geopolitical risks, including the trajectory of Middle East tensions and their impact on energy prices, add uncertainty to the inflation outlook. Sustained oil prices above $80 per barrel could complicate the Fed's policy calculus and disproportionately affect the transportation, manufacturing, and consumer-facing small-cap segments. Additionally, the post-reconstitution Russell 2000 — now carrying a reduced AI infrastructure weight — may see leadership rotate toward traditional cyclical sectors, regional banks, and biotech, altering the performance profile investors have grown accustomed to during the first half of 2026.

Capital flows into small-cap ETFs remain a critical signal. After years of investor capital concentrating in large-cap and thematic technology funds, the broadening of market participation in 2026 has driven renewed interest in small-cap strategies. Whether institutional and retail investors continue to allocate toward diversified small-cap vehicles like IWM — rather than narrower factor-based or active alternatives — will influence both fund flows and index-level momentum in the months ahead.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IWM

IWM in upward trend: price rose above 50-day moving average on August 03, 2026

IWM moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend. In of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IWM advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where IWM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IWM as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IWM turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IWM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IWM broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IWM entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Guardant Health (NASDAQ:GH), Arrowhead Pharmaceuticals (NASDAQ:ARWR), SSR Mining (NASDAQ:SSRM), Transocean Ltd (NYSE:RIG), Lumen Technologies (NYSE:LUMN), Valaris Limited (NYSE:VAL), Abercrombie & Fitch Co (NYSE:ANF), California Resources Corp (NYSE:CRC), Tanger (NYSE:SKT).

Industry description

The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The underlying index is a float-adjusted capitalization-weighted index of equity securities issued by the approximately 1,933 smallest issuers in the Russell 3000 Index. The fund may use derivatives to gain or reduce exposure to the components of the underlying index or exposure to one or more market risk factors associated with such components.

Market Cap

The average market capitalization across the iShares Russell 2000 ETF ETF is 2.72B. The market cap for tickers in the group ranges from 455.89K to 59.33B. BE holds the highest valuation in this group at 59.33B. The lowest valued company is ZSPC at 455.89K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Russell 2000 ETF ETF was 117%. For the same ETF, the average monthly price growth was 140%, and the average quarterly price growth was 785%. HOWL experienced the highest price growth at 116%, while BRCC experienced the biggest fall at -90%.

Volume

The average weekly volume growth across all stocks in the iShares Russell 2000 ETF ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
IWM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category SmallBlend

Profile
Details
Category
Small Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.